Forecasting the new case detection rate of leprosy in four states of Brazil: A comparison of modelling approaches. by Blok, David J et al.
Blok, DJ; Crump, RE; Sundaresh, R; Ndeffo-Mbah, M; Galvani, AP;
Porco, TC; de Vlas, SJ; Medley, GF; Richardus, JH (2017) Forecast-
ing the new case detection rate of leprosy in four states of Brazil:
A comparison of modelling approaches. Epidemics, 18. pp. 92-100.
ISSN 1755-4365 DOI: 10.1016/j.epidem.2017.01.005
Downloaded from: http://researchonline.lshtm.ac.uk/3615678/
DOI: 10.1016/j.epidem.2017.01.005
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
Epidemics 18 (2017) 92–100
Contents lists available at ScienceDirect
Epidemics
j our na l ho me  pa g e: www.elsev ier .com/ locate /ep idemics
Forecasting  the  new  case  detection  rate  of  leprosy  in  four  states  of
Brazil:  A  comparison  of  modelling  approaches
David  J.  Bloka,∗,1, Ronald  E.  Crumpb,1, Ram  Sundareshc,  Martial  Ndeffo-Mbahc,
Alison  P.  Galvanic,  Travis  C.  Porcod, Sake  J.  de  Vlasa, Graham  F.  Medleye,
Jan  Hendrik  Richardusa
a Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands
b Warwick Infectious Disease Epidemiology Research, School of Life Sciences, Gibbet Hill Campus, The University of Warwick, Coventry CV4 7AL, UK
c Yale University, Department of Public Health, USA
d FI Proctor Foundation for Research in Ophthalmology, University of California, San Francisco, CA 94143-0412 USA
e Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
a  r  t  i  c  l e  i  n  f  o
Article history:
Received 16 December 2016
Received in revised form 27 January 2017
Accepted 29 January 2017
Keywords:
Leprosy
Brazil
Model comparison
LMER
Back-calculation
Compartmental
Individual-based model
Forecast
a  b  s  t  r  a  c  t
Background:  Brazil  has  the second  highest  annual  number  of new  leprosy  cases.  The  aim of  this  study  is to
formally  compare  predictions  of  future  new  case  detection  rate  (NCDR)  trends  and  the  annual  probability
of NCDR  falling  below  10/100,000  of four  different  modelling  approaches  in  four  states  of  Brazil:  Rio
Grande  do Norte,  Amazonas,  Ceará,  Tocantins.
Methods:  A  linear  mixed  model,  a back-calculation  approach,  a deterministic  compartmental  model  and
an individual-based  model  were  used.  All  models  were  ﬁtted  to leprosy  data  obtained  from  the Brazilian
national  database  (SINAN).  First,  models  were  ﬁtted  to  the  data  up  to 2011,  and  predictions  were  made
for  NCDR  for  2012–2014.  Second,  data  up to  2014  were  considered  and forecasts  of NCDR  were  generated
for  each  year  from  2015  to  2040.  The  resulting  distributions  of  NCDR  and  the  probability  of NCDR  being
below  10/100,000  of the  population  for each  year  were  then  compared  between  approaches.
Results:  Each  model  performed  well  in model  ﬁtting  and the  short-term  forecasting  of future  NCDR.  Long-
term  forecasting  of  NCDR  and  the probability  of  NCDR  falling  below  10/100,000  differed  between  models.
All  agree  that the  trend  of  NCDR  will  continue  to  decrease  in  all  states  until  2040.  Reaching  a  NCDR  of  less
than  10/100,000  by 2020  was  only  likely  in  Rio  Grande  do  Norte.  Prediction  until  2040  showed  that  the
target  was also achieved  in  Amazonas,  while  in Ceará  and  Tocantins  the NCDR  most  likely  remain  (far)
above  10/100,000.
Conclusions:  All  models  agree  that, while  incidence  is  likely  to  decline,  achieving  a NCDR  below  10/100,000
by  2020  is  unlikely  in  some  states.  Long-term  prediction  showed  a  downward  trend  with  more  variation
between  models,  but  highlights  the  need  for  further  control  measures  to reduce  the  incidence  of  new
infections  if  leprosy  is  to be  eliminated.
© 2017  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Leprosy, or Hansen’s disease, is an infectious disease caused
primarily by Mycobacterium leprae.  It affects the skin, periph-
eral nerves, the mucosa of the upper respiratory tract and the
eyes (Leprosy, 1982). Most people are able to clear the bacterium
before disease occurs, or are resistant to the leprosy infection. The
∗ Corresponding author at: Erasmus MC,  University Medical Center Rotterdam PO
Box 2040, 3000 CA, Rotterdam, The Netherlands.
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most likely route of transmission of leprosy is through aerosols
(Hatta et al., 1995), with contacts closest to a patient with lep-
rosy, in particular within household contacts, having the highest
risk of acquiring the infection (Fine et al., 1997; Moet et al., 2006).
Detection of leprosy is based on clinical signs and classiﬁed into
paucibacillary (PB; ≤5 skin lesions) and multibacillary (MB; >5
skin lesions) leprosy. Currently, the main strategies to control
leprosy are early detection of cases, and treatment with mul-
tidrug therapy (Global leprosy update, 2015). Chemoprophylaxis
and immune-prophylaxis are both potential interventions but are
not yet routinely available.
http://dx.doi.org/10.1016/j.epidem.2017.01.005
1755-4365/© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
0/).
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Global elimination of leprosy has been a target for many years.
In 1991, the World Health Assembly set a goal for “elimination of
leprosy as a public health problem”, deﬁned as a prevalence of less
than 1 per 10,000, by the year 2000 (WHO, 1991). More recently,
the World Health Organization (WHO) has formulated new targets
for leprosy, which include global interruption of transmission or
elimination by 2020, and reduction of grade-2 disabilities in newly
detected cases to below 1 per million population at global level
by 2020 (WHO, 2012). Currently, worldwide, more than 200,000
new cases of leprosy are detected annually, with India, Brazil
and Indonesia accounting for around 80% of all new cases (Global
leprosy update, 2015). This incidence has remained fairly stable
over the past decade. Brazil has the second highest annual incidence
with approximately 31,000 new cases and annual new case detec-
tion rate (NCDR) of 15.32 per 100,000 population in 2014 (Ministry
of health, 2015). Brazil was one of the countries that did not achieve
elimination by 2000 (Castro et al., 2016). In 2011, the Ministry of
Health deﬁned an integrated action plan to reduce the burden of
leprosy and to eliminate leprosy as a public health problem by 2015.
This plan includes active case ﬁnding and timely provision of treat-
ment in prioritized municipalities, primarily located in the Amazon
region (Ministry of Health, 2012).
The spatial distribution of leprosy in Brazil is known to be het-
erogeneous with the highest number of cases in the Northern,
North-Eastern and Central-Western regions. Most high-risk states
or districts are part of the Brazilian Amazon (Penna et al., 2009;
Penna et al., 2013). In 2014, ten states (37%) had a NCDR of more
than 20 per 100,000, eight states (30%) a NCDR between 10 and 20
per 100,000, and nine states (33%) with a NCDR of less than 10 per
100,000 (Ministry of health, 2015). The highest rates can be found in
the hyperendemic states of Mato Grosso and Tocantins with NCDR
of 82.03 and 69.88 per 100,000, respectively. Also, within each state,
leprosy is known to be unevenly distributed (Alencar et al., 2012;
Kerr-Pontes et al., 2004). Although recent numbers show a slight
declining trend in most states, more than two thirds of the states
in Brazil can be regarded as highly endemic.
Although the WHO  target is the interruption of leprosy trans-
mission globally by 2020, it is clear that this will not be feasible due,
for example, to the long incubation time of leprosy. We  therefore
focus on the feasibility of reducing the NCDR to low levels, which is
likely to result in a reduced transmission. The aim of this study is to
compare four modelling approaches being applied to leprosy in the
context of assessing whether a NCDR of less than 10 per 100,000 can
be met  by 2020 and predicting the annual probability of NCDR being
below 10 per 100,000 in four states of Brazil: Rio Grande Do Norte
(low endemic), Amazonas (medium-high endemic), Ceará (high
endemic), and Tocantins (hyper endemic state). These states were
purposively selected based on differences in levels of endemicity
and historic patterns of leprosy NCDR.
Prediction of infectious disease patterns is complicated by the
intrinsic non-linearity in the transmission process: more transmis-
sion leads to more infection which leads to more disease which
leads to more transmission. Models are, by deﬁnition, abstract sim-
pliﬁcations of reality, and in order to have conﬁdence in their
results, need to be challenged and validated. The best way  to
develop consensus advice is through comparison of outputs of dif-
ferent models. Consequently, we applied two statistical models and
two mathematical transmission models to estimate future NCDR
of leprosy from the same data, including: a linear mixed model, a
Bayesian back-calculation approach, a deterministic compartmen-
tal model and the individual-based stochastic model SIMCOLEP.
Back-calculation has shown potential to estimate numbers of newly
infected individuals in Thailand (Crump and Medley, 2015). SIM-
COLEP, which models the transmission and control of leprosy in
a population structured by households, has been used to estimate
future NCDR trends in Bangladesh, India, Brazil, and Indonesia, and
to explore the potential impact of various interventions targeting
household contacts (Blok et al., 2015a; de Matos et al., 2016; Fischer
et al., 2011). In this study, we will explore the levels of agreement
between these methods on future projections of the NCDR in the
four chosen states. Model results are discussed to understand fac-
tors contributing to similarities and differences between methods.
2. Materials and methods
2.1. Data
Annual summary data by state were extracted via the SINAN
database’s web  interface (SINAN, 2016) for the years 1990–2012.
The SINAN database is the Brazilian government’s repository for
information on communicable diseases. The data retained for use
in this study consisted of the annual number of new cases diagnosed
(NC) and the annual new case discovery rate (NCDR) for MB  and PB
diagnoses combined, for 1990–2012, and for MB  cases separately,
from 2000 to 2012, along with the population size. Equivalent data
for 2013 and 2014 were retrieved from documents on the Brazil-
ian government’s health portal (Ministry of health, 2015; Ministry
of health, 2014). Population size and NCDR for MB  diagnoses were
not reported in the 2013 and 2014 data tables. However, the NCDR
for total diagnoses and the number of total diagnoses and MB diag-
noses were still included. Using the NCDR for total diagnoses and
the number of total diagnoses, we calculated the population size
and ﬁnally generated the NCDR for MB diagnoses for 2013 and
2014. Four states were chosen for inclusion in the study using
NCDR to indicate the level of endemicity in the state. The states
selected were Tocantins (NCDR in 2014 69.9 per 100,000), Ceará
(22.9), Amazonas (14.6) and Rio Grande do Norte (8.0) (Ministry of
health, 2015). The data for the four states are presented in Fig. 1.
2.2. Estimation approaches
The fundamental purpose is to compare four different meth-
ods for probabilistic forecasting of leprosy. Each method (whether
Bayesian or frequentist) yields the probability distribution of
future outcomes, i.e. results not used for training the model. Four
approaches were used: a linear mixed model, a Bayesian back-
calculation approach, a deterministic compartmental model, and
the individual-based stochastic model SIMCOLEP. In no case did we
use data used for ﬁtting or training as part of the test or evaluation
set. By bringing these models together, we can evaluate to what
extent predictions of NCDR are similar or different in order to vali-
date and to improve predictive quality. The next sections provide a
brief description of each approach with further details provided in
the supplementary materials S1–S3. The model code of the linear
mixed model, back-calculation approach and deterministic com-
partmental model are provided in supplementary material S5. The
model code of the individual-based model SIMCOLEP can be found
in Blok et al. (Blok et al., 2015a).
2.3. Linear mixed models
A standard linear mixed effects regression was ﬁtted to the data,
as in Brook et al. (Brook et al., 2015). Speciﬁcally, we  modelled
the log of the annual new case detection rate as a linear function
of time, with a random slope and intercept. We  used only years
2001–2011 for the ﬁtting. To model the uncertainty, we used the
Metropolis algorithm (a Markov chain Monte Carlo (MCMC) pro-
cedure) to estimate the posterior joint distribution of the ﬁxed
effect estimates (overall slope and intercept), the variance of the
random intercept and slope, and the residual error. Our  method
corresponds to a Bayesian analysis with noninformative priors; the
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Fig. 1. Observed new case detection rates (NCDR) and numbers of new cases (NC) for four Brazilian states. Data for combined paucibacillary and multibacillary diagnosis
types from 1990 to 2014 and for multibacillary diagnoses separately since 2001.
maximum posterior density occurs at the maximum likelihood esti-
mate. More speciﬁcally, we have assumed a random effect for the
slope and intercept for each state; all states were included in com-
mon  statistical model, though forecasts were only generated for the
four states under consideration. Finally, conditional on these esti-
mates, we simulated from the joint distribution of random effects
to project forward.
2.4. Back-calculation
Back-calculation utilises information on diagnoses and the time
between infection and diagnosis to make inferences about the
infection dynamics of infectious diseases. For discrete time peri-
ods the number of diagnoses in any given period is the sum of
the number of infections in the previous periods multiplied by the
probability of diagnosis in the current period given the infection
period. Leprosy can only be diagnosed in clinical cases, therefore
the time from infection to diagnosis can be subdivided into the
period from infection to onset of clinical symptoms (the incuba-
tion period) and from onset of clinical symptoms to diagnosis (the
detection delay). Crump and Medley (Crump and Medley, 2015)
applied back-calculation to the national annual summary data for
leprosy in Thailand. Here we use a similar model, with a two-stage
time between infection and diagnosis where the hazard of being
diagnosed in any year i given onset of symptoms in year j (j < i)
is scaled by a parameter which might be interpreted as diagnostic
effort or success within a period.
Parameters of the incubation period distribution (IPD) and
detection delay distribution (DDD) were estimated from a small
dataset with known, relatively short periods of exposure to leprosy
infection (Crump and Medley, 2015). A Bayesian MCMC  procedure
was used to generate samples from the joint posterior probability
distributions of these parameters which were subsequently used
in the back-calculation.
The back-calculation model was implemented in the Stan prob-
abilistic programming language (Stan Development Team, 2015)
and run in the R statistical environment (R Core Team, 2016) via
the rstan package (Stan Development Team, 2016). Details of the
model are given in the Supplementary Material (S1). The model was
similar to that of Crump and Medley (Crump and Medley, 2015)
with some methodological changes, including having the expected
number of new subclinical cases in a year be proportional to the
number of extant undiagnosed clinical cases and the lack of data
in the present study to inform the timing of changes in diagnostic
effort and absence of data on grade 2 disability diagnoses. Changes
in diagnostic effort were assumed to occur at the end of 1995, 2000
and 2007 for all analyses.
Resistance or susceptibility to leprosy and self-healing are not
accounted for in the back-calculation model. The data analysed are
the annual number of new cases diagnosed. As a result, the num-
bers of subclinical and clinical cases inferred by the model refer
speciﬁcally to those as-yet asymptomatic and symptomatic cases
that will result in diagnosed cases in the future.
For each sample from the joint posterior distribution of param-
eters included in the back-calculation model (diagnostic effort
parameters, the annual proportion of infective individuals giving
rise to a new subclinical case, the proportion of new diagnoses
which are MB  and the expected number of new diagnoses at equi-
librium) observed values were simulated across the time period.
New subclinical cases in each year were sampled from a negative
binomial distribution with expectation proportional to the size of
the infective pool and variance equal to the expectation squared.
Binomial sampling was  used to decide the year in which subclini-
cal cases became clinical (based on the hazard function of the IPD)
and clinical cases were diagnosed (based on the hazard function of
the DDD and the diagnostic effort parameters). More information
is provided in the Supplementary Material (S1).
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To incorporate the uncertainty about the IPD and DDD parame-
ters, multiple inference was used. The model was run repeatedly for
any dataset with a randomly selected set of IPD and DDD parame-
ters used in each run. Each of 1000 back-calculation runs were used
to generate 25 samples from the posterior probability distributions
of values associated with the infection process. The outputs from
these runs were combined post-analysis to give 25,000 samples for
each state-analysis combination. Estimates of NCDR were gener-
ated from the posterior samples of the numbers of new cases using
the same predictions of population size as used in the SIMCOLEP
simulations. Summary statistics of these 25,000 samples from the
posterior probability distributions form the primary results for this
model reported here: means, 2.5th and 97.5th percentiles and the
proportion of NCDR samples which less than 10/100,000.
2.5. Compartmental model
We  used a deterministic compartmental model similar to pre-
viously published models (Lechat et al., 1974; Lietman et al., 1997),
which includes compartments for susceptible non-infected indi-
viduals (whether Bacillus Calmette–Guérin (BCG) vaccinated or
not), latent infected individuals, symptomatic infected individuals,
and individuals who are both diagnosed and treated. The com-
partments for infected individuals are stratiﬁed into paucibacillary
and multibacillary leprosy infections (S2 Table 1). Flow from one
compartment to another is deﬁned by a directed acyclic graph
(S2 Fig. 1), and the dynamics of ﬂow from one compartment to
another is deﬁned by a set of differential equations (S2 Table 2)
that describe the change in size of these compartments over time.
These equations model the factors that affect ﬂow into and out of
each compartment.
A set of initial values for the state variables of these equations
and a set of values for the parameters (S2 Table 3) in these equations
is necessary and sufﬁcient to calculate model forecasts for a given
time period. In order to calculate these initial values and param-
eter values, the following approach was used: some values were
modelled as ﬁxed-values that were derived from relevant literature
(S2 Table 4), and some values were calculated using Markov Chain
Monte Carlo (MCMC) sampling from prior distributions derived
from relevant literature (S2 Table 5). This MCMC  process calculates
maximum-likelihood parameter values based on leprosy incidence
data for the years 2001–2011. Gelman-Rubin statistics were used to
evaluate chain convergence. The model is equivalent to a Bayesian
analysis with noninformative priors.
Once calculated, these initial values and parameter values were
used to generate a distribution of model forecasts. Residual vari-
ance from the training data was then applied to the model forecasts,
to more accurately capture the uncertainty in the data. This dis-
tribution of forecasts was then used to calculate a mean, 2.5th
percentile and 97.5th percentile model forecast for each forecast
year, in order to generate credible intervals for the model forecasts.
2.6. SIMCOLEP
The individual-based model SIMCOLEP simulates the spread
of M.  leprae in a population structured in households. Dynamics
of the population are described by births, movements between
households, and deaths. Births are determined by birth rates and
new-borns are placed in the household of their mother. Movements
of individuals to another newly created or existing household occur
after marriage, during adolescence or after becoming a widow(er).
Deaths are determined by death rates (Blok et al., 2015b; Fischer
et al., 2010).
In the model, transmission of M.  leprae occurs after direct con-
tact of a susceptible individual with an infectious individual. We
assumed that 20% of the population is susceptible (i.e. 80% will
not develop leprosy), based on the results of a previous modelling
study (Fischer et al., 2010). Since the mechanism that underlies
susceptibility is still unknown, susceptibility of an individual is
randomly determined at birth. Two  transmission processes are
modelled separately: transmission in the general population and
within-household transmission. Infectivity is determined by the
product of the contact rate and the probability of infection during
a contact. Each transmission process has its own  contact rate. An
infected individual will develop either PB or MB  leprosy, which is
randomly determined based on the distribution of the type of lep-
rosy in each state. In the model, both types can be detected, treated
and cured, but only MB leprosy is considered infectious. The natural
history of leprosy is modelled following Meima  et al. (Meima  et al.,
1999).
Leprosy control includes treatment with multidrug therapy
(MDT), passive case detection, and active case ﬁnding. Passive
case detection is reﬂected by estimated annual detection delays
(Gamma  distributed). Active case ﬁnding or household contact trac-
ing are based on annual coverage rates (Ministry of health, 2015).
After detection the patient is given MDT  treatment and considered
not to be infectious from then on. The model further assumes a
protective effect of 60% of BCG vaccination prior to the infection
(Schuring et al., 2009). Each state was modelled separately using
SIMCOLEP. First the distribution of household sizes was ﬁtted to
the data in each state. Afterwards, leprosy NCDR trends were ﬁtted
to the data by calibrating contact rates and detection delays. Based
on previous work, the contact rate within households was ﬁxed
at 0.98 (Fischer et al., 2010). The coverage of active case ﬁnding
was set to 43% since 2003 in all states (Ministry of Health, 2011).
For the long-term predictions, coverage rates were increased from
2014 onwards based on data (Ministry of health, 2015). The contact
rate in the general population and annual detection delays were
estimated for each state separately. Simulated new case detection
rates were compared to the data using a log-likelihood function
assuming a Poisson distribution. Using ﬁtted values future pre-
dictions were made for 2012–2014 and ﬁnally 2015–2040. Final
results were based on 1000 runs, which were used to calculate the
mean and the 2.5th and 97.5th percentile. The probability of future
NCDR being below 10 per 100,000 was calculated as the propor-
tion of runs in which the target was achieved. More information is
provided in the Supplementary Material (S3).
2.7. Analyses
Two  sets of analyses were performed with each approach. In the
ﬁrst, the ability of the models to forecast was evaluated by omitting
data from 2012 to 2014 and the models ﬁtted to the remaining data.
Short-term forecasts of NC and NCDR for the omitted data, for all
diagnoses and MB  diagnoses, were then compared between the
approaches and the data.
Each of the analyses gave a probability distribution for NC and
NCDR in the forecast years, for all and MB diagnoses. An approxi-
mate density function was ﬁtted to each of these using the logspline
package in R (Kooperberg, 2016) and the probability of the observed
data points for 2012–2014 were calculated from these densities.
The log likelihood of each observed value was  computed based
on the forecasted distribution (Bröcker and Smith, 2007), and the
sums of the log likelihood over the years 2012–2014 by state, vari-
able (NC and NCDR) and analysis for each diagnosis type (all or MB
diagnoses) were calculated as indicators of which analysis gave the
better short-term forecasts in these data sets.
Following this evaluation of the short-term model forecasts
using observed data, the models were used to forecast trends. All
of the data were included in the second analyses and forecasts of
NCDR for combined paucibacillary and multibacillary diagnoses
were generated for each year from 2015 to 2040. The resulting
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distributions of NCDR and probability of NCDR being below 10
per 100,000 of the population for each year were then compared
between approaches.
3. Results
Figs. 2–5 show the major results for NCDR of all diagnosed lep-
rosy cases. The ﬁgures relating to NC of all leprosy cases and both
NC and NCDR for multibacillary diagnoses are provided in the Sup-
plementary Material (S4).
Fig. 2 shows the mean and 95% forecast interval of predicted
NCDR values from analyses excluding 2012–2014 observations for
the period 1990–2014 from each model overlaid with the observed
data points. Generally, SIMCOLEP predictions appear to follow the
data more closely than the smoother ﬁt of the back-calculation
and the compartmental model, however all models provide a good
visual ﬁt to the observed data. There is noticeably more variation
in the predictions from the back-calculation but the difference in
variability varies between the States. Similar results are found for
the predicted NCDR of MB  cases and NC of all and MB  cases (See
S4).
The distribution of short-term forecasted NCDR values are pre-
sented by State and year in Fig. 3, this ﬁgure providing a more
detailed look at the forecast distributions included in Fig. 2 trends.
Almost all data points lie within the distribution of predicted fore-
casts for all models. Table 1 contains sum of log likelihoods for the
forecast data points for each analysis, with a higher (less nega-
tive) log likelihood indicating a better forecast. These values are
relative to each other and do not have an independent interpre-
tation. No model was clearly superior in terms of the sum of the
log likelihoods of the forecast data, with the highest values for each
analysis being shared evenly between SIMCOLEP, the compartmen-
tal model and the linear mixed model. The posterior densities for
the back-calculation model were very broad, giving lower density
at any given point.
Fig. 4 shows the longer-term forecasts of NCDR by state and year.
All modelling approaches predict a downward trend until 2040 in
all four states. In 2020, the median NCDR is expected to remain
above 10 per 100,000 in all states except for Rio Grande do Norte.
In general, the compartmental model and SIMCOLEP are more opti-
mistic than the back-calculation approach. This is also reﬂected
in the annual probability of NCDR falling below 10 per 100,000
(Fig. 5). According to the compartmental model and SIMCOLEP, the
probability of achieving the target increases to 100% in Rio Grande
do Norte from 2024 and 2025 onwards, respectively, whereas the
linear mixed model and the back-calculation predicts a steady
probability of 87% and 67%, respectively. In Amazonas the target can
be met  with 80% probability in 2027, 2022, 2029, and 2019 accord-
ing to the compartmental model, SIMCOLEP, back-calculation and
the linear mixed model, respectively. The predictions for Ceará also
show a discrepancy between the models. According to the linear-
mixed model, the back-calculation and SIMCOLEP, a NCDR below
10 per 100,000 is very unlikely in Ceará before 2040, while the
compartmental model predicts that it becomes more likely closer
to the year 2040. All models predict that Tocantins will not achieve
the target incidence within the modelled time span.
4. Discussion
This paper compared the results of four approaches with the
purpose to assess the feasibility of a NCDR below 10 per 100,000 by
2020 and to predict the annual probability of NCDR falling below
10 per 100,000 until 2040 in four states of Brazil. According to the
prediction of our models, this is only feasible by 2020 in the state
of Rio Grande do Norte. All models clearly showed that by 2020
the NCDR remains above 10 per 100,000 in Amazonas, Ceará and
Tocantins, indicating that the target will not be met. Long-term
predictions of the NCDR trend showed a downwards trend in all
states, assuming that Brazil continues the current level of effort
to control leprosy. Amazonas will likely achieve the target before
2040, while in Ceará and Tocantins the NCDR most likely remain
(far) above 10 per 100,000 in the modelled time frame.
Our ﬁndings highlight the need for a shift in the current lep-
rosy control strategy in order to achieve a NCDR of less than 10
per 100,000 in a reasonable time frame. Preventive interventions
should be targeted on contacts of leprosy patients, since they have
the highest risk of getting infected and developing clinical lep-
rosy (Moet et al., 2004). Examples of such interventions include
intensiﬁed contact tracing and providing chemoprophylaxis and/or
immunoprophylaxis (vaccination) to contacts. Chemoprophylaxis
with a single dose rifampicin is effective at preventing clinical lep-
rosy (Moet et al., 2008). Recent modelling work showed that when
provided in household contact only, it can speed up elimination (de
Matos et al., 2016).
All models performed well in short-term forecasting of future
diagnoses. Note that the performance of straightforward longitu-
dinal analysis was  comparable to the other procedures, with the
exception of MB  trends in Tocantins. Here, the regression contin-
ued to extrapolate a rising trend into the future, partially due to the
use of a separate regression model for each outcome and to the use
of a random effect for slope in the model. Other methods, such as
the use of exponentially weighted smoothing, would be more inﬂu-
enced by the most recent data points than those further in the past,
and may  have improved performance. Similarly, regression models
informed by prior distributions reﬂecting additional epidemiolog-
ical information (e.g., a long term rising trend is less credible when
all other regions are declining) may  perform better.
There is a great difference between models for the longer-term
forecasting of NCDR and the probability of NCDR falling below 10
per 100,000. The back-calculation does not include a mechanis-
tic description of transmission but new subclinical cases arise at a
rate proportional to the size of the infectious pool (with a naïve
deﬁnition of the infectious pool as being all the existing undi-
agnosed clinical cases). The change in NCDR beyond 2014 in the
back-calculation analysis is caused by a combination of the rate of
incidence of new subclinical cases, the diagnostic effort (assumed to
be the same as 2014) and population growth. The decline, as pre-
dicted by SIMCOLEP, can be attributed to leprosy control efforts.
The model assumed a continuation of the leprosy control in 2014
in each state. This also includes household contact tracing with a
coverage of 56%, 76%, 70%, and 85% in Rio Grande do Norte, Ama-
zonas, Ceará and Tocantins, respectively (Ministry of health, 2015).
Contact tracing and treatment further reduces transmission of lep-
rosy.
There is greater variability in the predicted values from the
back-calculation approach and this may  be due to the simulta-
neous estimation of the associated parameters (diagnostic effort,
multibacillary diagnosis proportion), the incorporation of uncer-
tainty about these parameters into the outcomes and the assumed
variation in simulating new subclinical infections. In contrast, pre-
dictions of SIMCOLEP were based on the best ﬁt of estimated
parameters, including the contact rate in the general population
and detection delays. Other parameters, such as MDT  treatment and
household contact tracing were ﬁxed to values obtained from data
and literature, which also reduces variability. One of the beneﬁts
of multi-model comparisons is that they expose the variability due
to model assumptions, but also exposes the differences in the way
that uncertainty is handled. There is clearly a trade-off between
models accurately reﬂecting uncertainty, and being sufﬁciently
precise to be useful to programme managers and policy makers.
The back-calculation approach has very few (model) assumptions,
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Fig. 2. Comparison of predicted trends from four modelling approaches with the observed new case detection rates of leprosy in four states of Brazil. Model outcomes are
represented by means (solid lines) and 95% prediction intervals (shaded areas).
Fig. 3. Distribution of forecasted new case detection rates of leprosy in 2012–2014 by state, as predicted by four modelling approaches. The observed value for each state-year
combination is indicated by a vertical black dashed line.
and no ﬁxed parameters, and more accurately reﬂects the possi-
bility that, for example, a large number of people were infected in
2015 and have yet to be diagnosed, i.e. there is no information on
the most recent infection rates. SIMCOLEP more accurately reﬂects
current understanding of infection and essentially rules out dra-
matic changes in infection rates. We  do not believe that there is a
formal solution to enable these differences to be reconciled.
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Fig. 4. Predicted long-term NCDR trends from four modelling approaches by year and state. The horizontal black dashed line marks the elimination as a public health problem
threshold of 10 new cases per 100,000. Model forecasts are represented by means (solid lines) and 95% prediction intervals (shaded areas).
Fig. 5. Probability of achieving a NCDR of less than 10 per 100,000 by year and state, as predicted by SIMCOLEP, compartmental, back-calculation and linear mixed models.
In this study we assessed the feasibility of reducing the NCDR
to lower levels as a ﬁrst step to achieve the target of interruption
of transmission. However, the NCDR is not a reliable indicator to
assess reduction of transmission, because it is also very dependent
on the control efforts in a state. A better benchmark for cutting
transmission would be to achieve zero leprosy cases among chil-
dren (Smith et al., 2014).
The quality of reported data remains a concern in this study.
The modelled States are among the poorest in Brazil, and they tend
to have long(er) detection delays, which results in a large number
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Table  1
Sum of log likelihood of observed data from 2012 to 2014 conditional on the outcomes of analyses to forecast these data by state and model.
State Variable Model Diagnoses
All MB
Rio Grande do Norte NCa SIMCOLEP −15.56 −14.23
Compartmental −15.22 −12.55
Back-calculation −18.39 −16.63
Linear mixed model −14.06 −11.84
NCDRb SIMCOLEP −5.11 −3.63
Compartmental −4.83 −1.89
Back-calculation −7.87 −6.12
Linear mixed model −4.53 −1.92
Amazonas NCa SIMCOLEP −17.33 −16.48
Compartmental −17.74 −17.04
Back-calculation −20.73 −19.39
Linear mixed model −21.05 −20.83
NCDRb SIMCOLEP −6.26 −5.50
Compartmental −5.27 −4.64
Back-calculation −9.86 −8.49
Linear mixed model −10.09 −9.76
Ceará  NCa SIMCOLEP −19.76 −18.83
Compartmental −18.53 −17.43
Back-calculation −24.23 −22.80
Linear mixed model −18.12 −16.38
NCDRb SIMCOLEP −6.37 −5.39
Compartmental −4.61 −3.74
Back-calculation −10.83 −9.42
Linear mixed model −4.85 −3.05
Tocantins NCa SIMCOLEP −17.33 −16.02
Compartmental −17.31 −18.01
Back-calculation −21.97 −20.17
Linear mixed model −20.42 −24.66
NCDRb SIMCOLEP −9.52 −7.99
Compartmental −11.10 −15.64
Back-calculation −13.96 −12.11
Linear mixed model −14.27 −23.07
a Number of new cases.
b New case detection rate.
of undiagnosed leprosy cases. Thus the national leprosy database,
SINAN, tends to underestimate the real numbers of cases (Kerr-
Pontes et al., 2004; Salgado et al., 2016). Targeted ﬁeld surveys
in the Amazon regions have resulted in many new cases detected
(Barreto et al., 2012; Salgado et al., 2012). These undiagnosed cases
remain a threat for breaking transmission in general (Smith et al.,
2015). Reported detection rates are known to reﬂect operational
variation in time, of which some are known and others unknown
(Penna et al., 2009). It is believed that migration, especially in
Tocantins, might explain to some extent the ﬂuctuation in NCDR
trends (Monteiro et al., 2015; Nobre et al., 2015). None of the models
includes speciﬁc assumptions about migration and the possibility
that cases are diagnosed in a State different from that in which they
were infected, and there is clearly a need for model development
to include movement.
Another consideration is the uneven distribution of leprosy in
each state (Alencar et al., 2012; Kerr-Pontes et al., 2004). A state
such as Rio Grande do Norte has (historically) relatively low NCDR,
but nevertheless contains hyper endemic municipalities (Nobre
et al., 2015). Although our models predict that Rio Grande do Norte
will very likely achieve the target of a NCDR below 10 per 100,000,
continuous control efforts remain needed to bring down leprosy in
high endemic municipalities.
5. Conclusions
The NCDR for leprosy is expected to continue to decline in Brazil,
if it keeps the current level of efforts to control leprosy. However,
these results show that the efforts made to achieve the gains to date
are required for many years to come, due to the long incubation
period of leprosy and hidden cases. By bringing together multiple
models we  have evaluated the trends using very different methods,
to give more robust insight on the likely future trends of the NCDR.
The model estimates suggest that there are high levels of ongoing
transmission in some of these states, meaning that control efforts
will need large increases in efﬁcacy to reduce the NCDR to low levels
over the next decade, and breaking transmission may  require a shift
in policy, such as providing post-exposure prophylaxis to contacts.
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